2,164
Views
7
CrossRef citations to date
0
Altmetric
Research Articles

Optimized self-microemulsifying drug delivery system improves the oral bioavailability and brain delivery of coenzyme Q10

, , , , , , , , , , & show all
Pages 2330-2342 | Received 01 Jun 2022, Accepted 04 Jul 2022, Published online: 19 Jul 2022

References

  • Abdel-Hamid S, Betz G. (2012). A novel tool for the prediction of tablet sticking during high speed compaction. Pharm Dev Technol 17:747–54.
  • Alehagen U, Alexander J, Aaseth J. (2016). Supplementation with selenium and coenzyme Q10 reduces cardiovascular mortality in elderly with low selenium status. A secondary analysis of a randomised clinical trial. PLoS One 11(7):1–16.
  • Arenas-Jal M, Sune-Negre JM, Garcia-Montoya E. (2020). Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges. Compr Rev Food Sci Food Saf 19:574–94.
  • Benet LZ. (2010). Predicting drug disposition via application of a biopharmaceutics drug disposition classification system. Basic Clin Pharmacol Toxicol 106:162–7.
  • Brocks DR, Davies NM. (2018). Lymphatic drug absorption via the enterocytes: pharmacokinetic simulation, modeling, and considerations for optimal drug development. J Pharm Pharm Sci 21:254s–70s.
  • Buya AB, Beloqui A, Memvanga PB, et al. (2020). Self-nano-emulsifying drug-delivery systems: from the development to the current applications and challenges in oral drug delivery. Pharmaceutics 12:1194.
  • Cherniakov I, Domb AJ, Hoffman A. (2015). Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects. Expert Opin Drug Deliv 12:1121–33.
  • Czajkowska-Kośnik A, Szekalska M, Amelian A, et al. (2015). Development and evaluation of liquid and solid self-emulsifying drug delivery systems for atorvastatin. Molecules 20:21010–22.
  • Davis BM, Tian K, Pahlitzsch M, et al. (2017). Topical coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension. Mitochondrion 36:114–23.
  • Dhanasekaran M, Ren J. (2005). The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus. Curr Neurovasc Res 2:447–59.
  • Diaz-Casado ME, et al. (2019). The paradox of coenzyme Q10 in aging. Nutrients 11:1–33.
  • Dokania S, Joshi AK. (2015). Self-microemulsifying drug delivery system (SMEDDS)–challenges and road ahead. Drug Deliv 22:675–90.
  • Fan L, Feng Y, Chen G-C, et al. (2017). Effects of coenzyme Q10 supplementation on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 119:128–36.
  • Fir MM, Smidovnik A, Milivojevic L, et al. (2009). Studies of CoQ10 and cyclodextrin complexes: solubility, thermo- and photo-stability. J Incl Phenom Macrocycl Chem 64:225–32.
  • Fuller B, Smith D, Howerton A, et al. (2006). Anti-inflammatory effects of CoQ10 and colorless carotenoids. J Cosmet Dermatol 5:30–8.
  • Garg T, Rath G, Goyal AK. (2015). Colloidal drug delivery systems: current status and future directions. Crit Rev Ther Drug Carrier Syst 32:89–147.
  • Hernandez-Camacho JD, et al. (2018). Coenzyme Q10 supplementation in aging and disease. Front Physiol 9:44.
  • Hidaka T, Fujii K, Funahashi I, et al. (2008). Safety assessment of coenzyme Q10 (CoQ10). Biofactors 32:199–208.,
  • Itagaki S, Ochiai A, Kobayashi M, et al. (2008). Interaction of coenzyme Q10 with the intestinal drug transporter P-glycoprotein. J Agric Food Chem 56:6923–7.
  • Johal HS, Garg T, Rath G, et al. (2016). Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv 23:550–63.
  • Joshi D, Garg T, Goyal AK, et al. (2016). Advanced drug delivery approaches against periodontitis. Drug Deliv 23:363–77.
  • Kamboj S, Rana V. (2016). Quality-by-design based development of a self-microemulsifying drug delivery system to reduce the effect of food on Nelfinavir mesylate. Int J Pharm 501:311–25.
  • Karun Kataria AS, T, GargAmit K, Goyal, et al. (2014). Novel technology to improve drug loading in polymeric nanofibers. Drug Delivery Letters 4:7.
  • Khattab A, Hassanin L, Zaki N. (2017). Self-nanoemulsifying drug delivery system of coenzyme (Q10) with improved dissolution, bioavailability, and protective efficiency on liver fibrosis. AAPS PharmSciTech 18:1657–72.
  • Kollipara S, Gandhi RK. (2014). Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations. Acta Pharm Sin B 4:333–49.
  • Kumar D, Jacob D, PS S, et al. (2016). Enhanced bioavailability and relative distribution of free (unconjugated) curcuminoids following the oral administration of a food-grade formulation with fenugreek dietary fibre: A randomised double-blind crossover study. J Funct Foods 22:578–87.
  • Laredj LN, Licitra F, Puccio HM. (2014). The molecular genetics of coenzyme Q biosynthesis in health and disease. Biochimie 100:78–87.
  • Lopez-Lluch G, et al. (2010). Is coenzyme Q a key factor in aging? Mech Ageing Dev 131:225–35.
  • Miles MV. (2007). The uptake and distribution of coenzyme Q10. Mitochondrion 7 Suppl:S72–S7.
  • Mortensen SA, Rosenfeldt F, Kumar A, Q-SYMBIO Study Investigators, et al. (2014). The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail 2:641–9.
  • Nakamura S, Otsuka N, Yoshino Y, et al. (2016). Predicting the occurrence of sticking during tablet production by shear testing of a pharmaceutical powder. Chem Pharm Bull (Tokyo) 64:512–6.
  • Nerella NG, Block LH, Noonan PK. (1993). The impact of lag time on the estimation of pharmacokinetic parameters. I. One-compartment open model. Pharm Res 10:1031–6.
  • Noh G, Keum T, Bashyal S, et al. (2022). Recent progress in hydrophobic ion-pairing and lipid-based drug delivery systems for enhanced oral delivery of biopharmaceuticals. J Pharm Investig 52:75–93.
  • O’Driscoll CM. (2002). Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 15:405–15.
  • Pan X-M, Li J, Gan R, et al. (2015). Preparation and in vitro evaluation of enteric-coated tablets of rosiglitazone sodium. Saudi Pharm J 23:581–6.
  • Papich MG, Martinez MN. (2015). Applying biopharmaceutical classification system (BCS) criteria to predict oral absorption of drugs in dogs: challenges and pitfalls. Aaps J 17:948–64.
  • Porter CJ, Trevaskis NL, Charman WN. (2007). Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 6:231–48.
  • Potgieter M, Pretorius E, Pepper MS. (2013). Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation. Nutr Rev 71:180–8.
  • Rani S, Rana R, Saraogi GK, et al. (2019). Self-emulsifying oral lipid drug delivery systems: advances and challenges. AAPS PharmSciTech 20:129.
  • Saengsorn K, Jimtaisong A. (2017). Determination of hydrophilic–lipophilic balance value and emulsion properties of sacha inchi oil. Asian Pacific Journal of Tropical Biomedicine 7:1092–6.
  • Shah B. (2021). Microemulsion as a promising carrier for nose to brain delivery: journey since last decade. J Pharm Investig 51:611–34.
  • Shin D, Chae B, Goo Y, et al. (2019). Improved dissolution and oral bioavailability of valsartan using a solidified supersaturable self-microemulsifying drug delivery system containing Gelucire(®) 44/14. Pharmaceutics 11:58.
  • Singh B, Bandopadhyay S, Kapil R, et al. (2009). Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst 26:427–521.
  • Sweed NM, Fayez AM, El-Emam SZ, et al. (2021). Response surface optimization of self nano-emulsifying drug delivery system of rosuvastatin calcium for hepatocellular carcinoma. J Pharm Investig 51:85–101.
  • Tran P, Park J-S. (2021). Recent trends of self-emulsifying drug delivery system for enhancing the oral bioavailability of poorly water-soluble drugs. J Pharm Investig 51:439–63.
  • Veeravalli V, Cheruvu HS, Srivastava P, Vamsi Madgula LM. (2020). Three-dimensional aspects of formulation excipients in drug discovery: a critical assessment on orphan excipients, matrix effects and drug interactions. J Pharm Anal 10:522–31.
  • Visetvichaporn V, Kim K-H, Jung K, et al. (2020). Formulation of self-microemulsifying drug delivery system (SMEDDS) by D-optimal mixture design to enhance the oral bioavailability of a new cathepsin K inhibitor (HL235). Int J Pharm 573:118772.
  • Wu CY, Benet LZ, Hebert MF, et al. (1995). Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine. Clin Pharmacol Ther 58:492–7.
  • Xia S, Xu S, Zhang X. (2006). Optimization in the preparation of coenzyme Q10 nanoliposomes. J Agric Food Chem 54:6358–66.
  • Yeom DW, Song YS, Kim SR, et al. (2015). Development and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using D-optimal mixture design. Int J Nanomedicine 10:3865–77.
  • Yue Y, Zhou H, Liu G, et al. (2010). The advantages of a novel CoQ10 delivery system in skin photo-protection. Int J Pharm 392:57–63.
  • Zhang H, Yao M, Morrison RA, et al. (2003). Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats. Arch Pharm Res 26:768–72.
  • Zupančič O, Grieβinger JA, Rohrer J, et al. (2016). Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration. Eur J Pharm Biopharm 109:113–21.